Ratifye addresses these challenges through cryptographically authenticated barcodes that are layered onto India’s existing GS1 (GTIN) barcode infrastructure — the same barcodes already printed on pharmaceutical products by GS1 India member manufacturers. The platform requires no new hardware, no changes to existing labelling or packaging workflows, and can be deployed on an existing pharma manufacturer’s infrastructure within two weeks. Key capabilities include: (a) Real-Time Authentication: Every scan at any node in the supply chain — manufacturer, distributor, stockist, retailer, or patient — returns an instant authentic/not-authentic verification signal; (b) End-to-End Track and Trace: Batch and serial-level traceability from the manufacturing line to the point of dispensing, fully GS1 compliant and EPCIS-compatible; (c) Market Diversion Detection: Real-time alerts when a product is scanned in a geography inconsistent with its invoiced distribution path, of particular relevance to government-supply and subsidised medicines; (d) Expiry Management: FEFO (First Expiry, First Out) enforcement and early-expiry alerts across all distribution nodes, reducing the incidence of expired products reaching patients;

Ratifye

Complete GS1 barcode platform — generation & authentication

Complete GS1 barcode platform — generation & authentication